You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
In this issue of Science Translational Medicine, El-Khatib et al. describe a “closed-loop” bihormonal artificial pancreas, designed to avert episodes of low blood sugar in patients with insulin-dependent diabetes. We discuss the benefits and challenges of therapy directed at tight control of blood glucose and ask whether this and similar technological breakthroughs can address as yet unanswered questions in the biology of diabetes.
Footnotes
-
Citation: L. Brown, E. R. Edelman, Optimal control of blood glucose: The diabetic patient or the machine? Sci. Transl. Med. 2, 27ps18 (2010).
- Copyright © 2010, American Association for the Advancement of Science
